I-MAB logo

I-MAB - ADR

NAS:IMAB (China)   ADR
$ 1.80 0 (0%) 10:09 PM EST
At Loss
P/B:
0.43
Market Cap:
$ 145.26M
Enterprise V:
$ -255.19M
Volume:
204.84K
Avg Vol (2M):
304.50K
Also Trade In:
Volume:
204.84K
At Loss
Avg Vol (2M):
304.50K

Business Description

Description
I-Mab Biopharma is a clinical-stage biotech company in China that listed on Nasdaq in January 2020. Its first commercial drug will likely be eftansomatropin, a long-acting growth hormone that has a large market in China among pediatric patients with short stature, which we estimate will launch in 2024 or 2025. Other core assets include lemzoparlimab, a potential best-in-class CD47 inhibitor in phase 2 trials; uliledlimab, a potential best-in-class CD73 inhibitor in phase 2 trials; and felzartamab for the Chinese market, a CD38 inhibitor for multiple myeloma, which could have a phase 3 data readout in 2023.

Financials (Next Earnings Date:2024-08-16 Est.)

IMAB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IMAB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

I-MAB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) -36.474
EPS (TTM) ($) -3.828
Beta 1.21
Volatility % 54.92
14-Day RSI 48.51
14-Day ATR ($) 0.072037
20-Day SMA ($) 1.8155
12-1 Month Momentum % -44.18
52-Week Range ($) 1.16 - 3.45
Shares Outstanding (Mil) 80.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

I-MAB Filings

Filing Date Document Date Form
No Filing Data

I-MAB Stock Events

Financials Calendars
Event Date Price($)
No Event Data

I-MAB Frequently Asked Questions

What is I-MAB(IMAB)'s stock price today?
The current price of IMAB is $1.80. The 52 week high of IMAB is $3.45 and 52 week low is $1.16.
When is next earnings date of I-MAB(IMAB)?
The next earnings date of I-MAB(IMAB) is 2024-08-16 Est..
Does I-MAB(IMAB) pay dividends? If so, how much?
I-MAB(IMAB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1